close
Generic biolab medicine box
BIOLAB FARMA
PRODUCT
DACXI 20MG X 28 COATED TABLETS
BRIEF DESCRIPTION/INDICATION

DACXI® is part of the therapeutic class known as antithrombotic agents, whose action prevents the formation of thrombi. DACXI® is indicated for Prevention of stroke and clot formation in other blood vessels (systemic embolism); Treatment and prevention of deep vein thrombosis; Treatment and prevention of pulmonary embolism; Treatment and prevention of thromboembolism.
Rivaroxaban prevents the formation of blood clots inside blood vessels by inhibiting coagulation factor Xa, the agent responsible for clot formation by amplifying coagulation. DACXI® has different inactivation pathways for factor Xa
DACXI® comes in the following presentations: 10mg (30 tablets), 15mg (28 tablets) and 20mg (28 tablets).

PRESENTATION

Coated tablet

THERAPEUTIC CLASS

Antithrombotics

CLASSIFICATION

Sale on prescription

COMPOSITE
RIVAROXABANA
See leaflet
IF SYMPTOMS PERSIST, THE DOCTOR SHOULD BE CONSULTED.
Related products
Copyright © Biolab | Rights Reserved - 2024